Press Releases

August 30, 2023
Sydnexis Welcomes Nick Ruth as Chief Commercial Officer
Sydnexis is excited to announce the appointment of Nick Ruth, MBA, as its Chief Commercial Officer.
Read More
August 15, 2023
Sydnexis Featured in Review of Myopia Management
To learn more directly from the founders of Sydnexis about what makes their formula unique and how it will benefit juvenile-onset myopic children, Review of Myopia Management caught up with Gregory Ostrow, MD, and Patrick Johnson, PhD, and conducted the following interview.
Read More
August 10, 2021
Sydnexis Secures $45 Million Series B
Financing Led by Visionary Ventures and Bluestem Capital
Read More
May 15, 2021
Sydnexis Completes Enrollment in Phase 3 Clinical Trial
See more at
Read More
April 10, 2021
Sydnexis Executes Exclusive License with Santen
Santen SA and Sydnexis Inc. announce the signing of an exclusive licensing agreement for SYD-101.
Read More